Charu Kothari
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance.
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance.
Journal: Nucleic acids research
Published: December 13, 2022
TBC1D9: An Important Modulator of Tumorigenesis in Breast Cancer.
Journal: Cancers
Published: June 14, 2021
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
Journal: Cancers
Published: February 23, 2021
The Importance of Breast Adipose Tissue in Breast Cancer.
Journal: International journal of molecular sciences
Published: June 22, 2020
Machine learning analysis identifies genes differentiating triple negative breast cancers.
Journal: Scientific reports
Published: February 26, 2020
Gene signatures of breast cancer development and the potential for novel targeted treatments.
Journal: Pharmacogenomics
Published: January 23, 2020
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
Journal: Cancer research
Published: January 17, 2020
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy.
Journal: Oncotarget
Published: July 04, 2018
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
Journal: Cancer research
Published: June 29, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026